Stanisław Boryczka Selected Research

betulin

2/2022	The Influence of Betulin and Its Derivatives EB5 and ECH147 on the Antioxidant Status of Human Renal Proximal Tubule Epithelial Cells.
11/2021	Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines.
1/2021	Molecular Structure, In Vitro Anticancer Study and Molecular Docking of New Phosphate Derivatives of Betulin.
1/2021	Anticancer Activity of the Acetylenic Derivative of Betulin Phosphate Involves Induction of Necrotic-Like Death in Breast Cancer Cells In Vitro.
11/2020	Synthetic Betulin Derivatives Inhibit Growth of Glioma Cells In Vitro.
1/2020	Phosphate Derivatives of 3-Carboxyacylbetulin: SynThesis, In Vitro Anti-HIV and Molecular Docking Study.
2/2019	Bioresorbable filomicelles for targeted delivery of betulin derivative - In vitro study.
1/2019	New phosphate derivatives of betulin as anticancer agents: Synthesis, crystal structure, and molecular docking study.
11/2017	Acetylenic derivative of betulin induces apoptosis in endometrial adenocarcinoma cell line.
1/2017	New acetylenic derivatives of betulin and betulone, synthesis and cytotoxic activity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stanisław Boryczka Research Topics

Disease

15	Neoplasms (Cancer) 02/2022 - 12/2012
6	Melanoma (Melanoma, Malignant) 08/2020 - 02/2014
5	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2013
4	Amelanotic Melanoma (Amelanotic Melanomas) 01/2021 - 12/2016
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2018
2	Adenocarcinoma 03/2019 - 11/2017
2	Ductal Carcinoma 01/2018 - 11/2017
2	Leukemia P388 01/2017 - 04/2013
2	Leukemia 01/2017 - 04/2013
1	Rhabdomyosarcoma 11/2021
1	Neuroblastoma 11/2021
1	Necrosis 01/2021
1	COVID-19 12/2020
1	Glioma (Gliomas) 11/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Carcinoma (Carcinomatosis) 02/2019

Drug/Important Bio-Agent (IBA)

14	betulinIBA 02/2022 - 04/2013
5	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 04/2013
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
4	28-O-propynoylbetulinIBA 11/2017 - 04/2013
3	TriterpenesIBA 11/2021 - 03/2019
2	Pharmaceutical PreparationsIBA 11/2021 - 08/2020
2	Phosphates (Orthophosphate)IBA 01/2021 - 02/2019
2	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2020 - 08/2020
2	Biological ProductsIBA 01/2017 - 12/2012
1	Organophosphonates (Phosphonates)IBA 02/2022
1	Phosphotransferases (Kinase)IBA 11/2021
1	PhytochemicalsIBA 11/2021
1	Temozolomide (Temodar)FDA LinkGeneric 11/2021
1	CaspasesIBA 01/2021
1	Moxifloxacin (Avelox)FDA Link 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	DeoxyuridineIBA 11/2020
1	Bromodeoxyuridine (BrdU)IBA 11/2020
1	Microphthalmia-Associated Transcription FactorIBA 08/2020
1	FluoroquinolonesIBA 08/2020
1	lupaneIBA 01/2020
1	Betulinic AcidIBA 01/2020
1	Pentacyclic TriterpenesIBA 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2019
1	TriazolesIBA 01/2018
1	ThymidineIBA 01/2018
1	Caspase 3 (Caspase-3)IBA 12/2016
1	AcidsIBA 12/2012

Therapy/Procedure

1	Aftercare (After-Treatment) 11/2021
1	Therapeutics 01/2020